Association between the Clara cell secretory protein (CC16) G38A polymorphism and the progression of IgA nephropathy

Clinical Nephrology

Volumn 67, Issue 2, 2007, Pages 73-80

  Lim, C S ^a,b   Kim, S M ^b   Oh, Y K ^a,b   Kim, Y S ^b   Chae, D W ^b   Han, J S ^b   Kim, S ^b   Lee, J S ^b   Yoon, H J ^c  

^a Seoul National University Boramae Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul Clinical Genomics Inc   (South Korea)

Author keywords

Clara cell secretory protein; Genetic polymorphism; IgA nephropathy; IgAN prognosis; Renal survival

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CLARA CELL PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; EXON; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; KAPLAN MEIER METHOD; KIDNEY BIOPSY; KOREA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SURVIVAL;

EID: 33847244889     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP67073     Document Type: Article

References (33)

1. Alamartine E, Sabatier JC, Guerin C, Berliet JM, Berthoux F. Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multi-variate analyses. Am J Kidney Dis. 1991; 18: 12-19.
2. Bantis C, Ivens K, Kreusser W, Koch M, Klem-Vehne N, Grabensee B, Heering P. Influence of genetic polymorphisms of the renin-angiotensin system on IgA nephropathy. Am J Nephrol. 2004; 24: 258-267.
3. Candelaria PV, Backer V, Laing IA, Porsbjerg C, Nepper-Christensen S, de Klerk N, Goldblatt J, Le Souiëf PN. Association between asthma-related phenotypes and the CC16 A38G polymorphism in an unselected population of young adult Danes. Immunogenetics. 2005; 57: 25-32.
4. Chow KM, Wong TY, Li PK. Genetics of common progressive renal disease. Kidney Int. 2005; 67 (Suppl 94): S41-S45.
5. Coppo R, Chiesa M, Cirina P, Peruzzi L, Amore A. In human IgA nephropathy uteroglobin does not play the role inferred from transgenic mice. Am J Kidney Dis. 2002; 40: 495-503.
6. D'Amico G, Minetti L, Ponticelli C, Fellin G, Ferrario F, Barbiano di Belgioioso G, Imbasciati E, Ragni A, Bertoli S, Fogazzi G. Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med. 1986; 59: 363-378.
7. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol. 2004; 24: 179-196.
8. Dierynck I, Bernard A, Roels H, De Ley M. Potent inhibition of both human interferon-gamma production and biologic activity by the Clara cell protein CC-16. Am J Respir Cell Mol Biol. 1995; 12: 205-210.
9. Donadio JV Jr, Grande JP. Immunoglobulin A nephropathy: a clinical perspective. J Am Soc Nephrol. 1997; 8: 1324-1332.
10. George AL Jr, Neilson EG. Genetics of kidney disease. Am J Kidney Dis. 2000; 35 (Suppl 1): S160-S169.
11. Goumenos DS, Brown CB. Therapeutic approach of patients with IgA nephropathy. Ren Fail. 2004; 26: 171-177.
12. Hsu SI, Ramirez SB, Winn MP, Bonventre JV, Owen WF. Evidence for genetic factors in the development and progressionof IgA nephropathy. Kidney Int. 2000; 57: 1818-1835.
13. Kim YS, Kang D, Kwon DY, Park WY, Kim H, Lee DS, Lim CS, Han JS, Kim S, Lee JS. Uteroglobin gene polymorphisms affect the progression of immunoglobulin A nephropathy by modulating the level of uteroglobin expression. Pharmacogenetics. 2001; 11: 299-305.
14. Laing IA, Goldblatt J, Eber E, Hayden CM, Rye PJ, Gibson NA, Palmer LJ, Burton PR, Le Souêf PN. A polymorphism of the CC16 gene is associated with an increased risk of asthma. J Med Genet. 1998; 35: 463-467.
15. Laing IA, Hermans C, Bernard A, Burton PR, Goldblatt J, Le Souêf PN. Association between plasma CC16 levels, the A38G polymorphism, and asthma. Am J Res Crit Care Med. 2000; 161: 124-127.
16. Lee DS, Yang SH, Kim HL, Joo KW, Lim CS, Chae DW, Kim S, Lee JS, Kim YS. Recombinant uteroglobin prevents the experimental crescentic glomerulonephritis. Kidney Int. 2004; 66: 1061-1067.
17. Lu JC, Zhang H, Chen YQ, Liu G, Wang HY. Uteroglobin G38A polymorphism is associated with the progression of IgA nephropathy in Chinese patients. Zhonghua Nei Ke Za Zhi. 2004; 43: 37-40.
18. Matsunaga A, Numakura C, Kawakami T, Itoh Y, Kawabata I, Masakane I, Suzuki T, Suzuki M, Goto T, Itoh K, Hayasaka K. Association of the uteroglobin gene polymorphism with IgA nephropathy. Am J Kidney Dis. 2002; 39: 36-41.
19. Menegatti E, Roccatello D, Fadden K, Piccoli G, De Rosa G, Sena LM, Rifai A. Gene expression of 5-lipoxygenase and LTA4 hydrolase in renal tissue of nephrotic syndrome patients. Clin Exp Immunol. 1999; 116: 347-353.
20. Menegatti E, Nardacchione A, Alpa M, Agnes C, Rossi D, Chiara M, Modena V, Sena LM, Roccatello D. Polymorphism of the uteroglobin gene in systemic lupus erythematosus and IgA nephropathy. Lab Invest. 2002; 82: 543-546.
21. Miele L, Cordella-Miele E, Mantile G, Peri A, Mukherjee AB. Uteroglobin and uteroglobin-like proteins: the uteroglobin family of proteins. J Endocrinol Invest. 1994; 17: 679-692.
22. Mukherjee AB, Kundu GC, Mantile-Selvaggi G, Yuan CJ, Mandal AK, Chattopadhyay S, Zheng F, Pattabiraman N, Zhang Z. Uteroglobin: a novel cytokine? Cell Mol Life Sci. 1999; 55: 771-787.
23. Narita I, Saito N, Goto S, Jin S, Omori K, Sakatsume M, Gejyo F. Role of uteroglobin G38A polymorphism in the progression of IgA nephropathy in Japanese patients. Kidney Int. 2002; 61: 1853-1858.
24. Peri A, Cordella-Miele E, Miele L, Mukherjee AB. Tissue-specific expression of the gene coding for human Clara cell 10 kD protein, a phospholipase A2-inhibitory protein. J Clin Invest. 1993; 92: 2099-2109.
25. Sengler C, Hainzmann A, Jerkic SP, Haider A, Sommerfeld C, Niggemann B, Lau S, Forster J, Schuster A, Kamin W, Bauer C, Laing I, LeSouef P, Wahn U, Deichmann K, Nickel R. Clara cell protein 16 (CC16) gene polymorphism influences the degree of airway responsiveness in asthmatic children. J Allergy Clin Immunol. 2003; 111: 515-519.
26. Syrjänen J, Huang XH, Mustonen J, Koivula T, Lehtimaki T, Pasternack A. Angiotensin-converting enzyme insertion/deletion polymorphism and prognosis of IgA nephropathy. Nephron. 2000; 86: 115-121.
27. Syrjänen J, Hurme M, Lehtimaki T, Mustonen J, Pasternack A. Polymorphism of the cytokine genes and IgA nephropathy. Kidney Int. 2002; 61: 1079-1085.
28. Szelestei T, Bahring S, Kovacs T, Vas T, Salamon C, Busjahn A, Luft FC, Nagy J. Association of a uteroglobin polymorphism with rate of progression in patients with IgA nephropathy. Am J Kidney Dis. 2000; 36: 468-473.
29. Vasanthakumar G, Manjunath R, Mukherjee AB, Wirabi H, Schiffmann E. Inhibition of phagocyte chemotaxis by uteroglobin, an inhibitor of blastocyst rejection. Biochem Pharmacol. 1988; 37: 389-394.
30. Yong D, QingQing W, Hua L, Yang LX, QingLing Z, Ying H, QiaoJing Q, HanChao S. Association of uteroglobin G38A polymorphism with IgA nephropathy: a meta-analysis. Am J Kidney Dis. 2006; 48: 1-7.
31. Zhang Z, Kundu GC, Yuan CJ, Ward JM, Lee EJ, DeMayo F, Westphal H, Mukherjee AB. Severe fibronectin-deposit renal glomerular disease in mice lacking uteroglobin. Science. 1997; 276: 1408-1412.
32. Zhang Z, Zimonjic DB, Popescu NC, Wang N, Gerhard DS, Stone EM, Arbour NC, De Vries HG, Scheffer H, Gerritsen J, Collée JM, Ten Kate LP, Mukheriee AB. Human uteroglobin gene: structure, subchromosomal localization, and polymorphism. DNA Cell Biol. 1997; 16: 73-83.
33. Zheng F, Kundu GC, Zhang Z, Ward J, DeMayo F, Mukherjee AB. 1999 Uteroglobin is essential in preventing immunoglobulin A nephropathy in mice. Nat Med. 1999; 5: 1018-1025.